Showing results (221-230 of 537) with videos related to
Sort By:
Pageof 54
Tumori|October 31, 1983
MOPP treatment of resistant Hodgkin's disease following ABVD failureG Cimino, A P Anselmo, A Marzullo, et al.Blut|August 1, 1986
Decreased NK activity in hairy cell leukemia (HCL): an analysis at the cellular levelL Fontana, G De Rossi, G De Sanctis, et al.Journal of Biological Regulators and Homeostatic Agents|July 1, 1992
In vitro antitumor effect of LAK cells and alpha interferon in combination on tumor cell linesA Sandrelli, P De Fabritiis, G D Di Nucci, et al.Leukemia & Lymphoma|January 1, 1993
What does one do for the CML patient in relapse after allogeneic bone marrow transplantation?W Arcese, A P Iori, G Di Nucci, et al.Scandinavian Journal of Haematology|October 1, 1986
Pipobroman therapy of essential thrombocythemiaM G Mazzucconi, M Francesconi, A Chistolini, et al.Haematologica|August 27, 1998
Combined modality therapy in advanced Hodgkin's disease: a report on 218 patients with a median follow-up of eight yearsA P Anselmo, E Cavalieri, R M Enrici, et al.Nouvelle Revue Francaise D'Hematologie|August 1, 1993
CD5 negative lymphocytosis mimicking typical B-chronic lymphocytic leukaemia. Description of 26 casesG De Rossi, F R Mauro, F Lo Coco, et al.Cancer|March 1, 1978
Lack of prognostic significance of the pretreatment labeling and mitotic indices of marrow blasts in acute nonlymphocytic leukemia (ANLL)S Amadori, M C Petti, A De Francesco, et al.European Journal of Haematology|January 18, 2006
Idiopathic thrombocytopenic purpura (ITP) in the elderly: clinical course in 178 patientsL Bizzoni, M G Mazzucconi, M Gentile, et al.Onkologie|February 1, 1988
Deoxycoformycin in therapy of refractory lymphoid neoplasmsA D Ho, J Thaler, R Kuse, et al.Pageof 54